← Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
UNC NC NEXUS newborn exome sequencing study
Also known as: NC NEXUS, North Carolina Newborn Exome Sequencing for Universal Screening, Well infant whole exome sequencing, Diagnosed whole exome sequencing
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Genetic/Diagnostic Sequencing
Stage
Not applicable
Status
Completed
Target Gene
—
Route / Mode
Saliva sample genetic testing
Confidence
88%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
United States
Population
newborn, pediatric, genetic, screening
Trial IDs
1
Mechanism
Whole-exome sequencing study evaluating newborn screening utility and parental decision-making for conditions including hearing loss and hereditary disease.
Indications
Notes
Registry-verified diagnostic sequencing study. This is not a therapeutic gene-therapy program and should remain in the diagnostic silo.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT02826694
Key Events
2019-06-30
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencemerged-generated-intervention-armsdiagnostic-screening-studygenetic-testing-not-gene-therapystudy-level-not-standalone-product
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed